Delcath Systems, Inc.
(DCTH - NASDAQ)
10,84 USD
📋 Profilo Aziendale

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.

|